Last reviewed · How we verify
Endovascular Brachytherapy Combined With Stent Placement and Transcatheter Arterial Chemoembolization (TACE) for Treatment of HCC With Main Portal Vein Tumor Thrombus Versus TACE Alone: a Prospective Randomized Controlled Multicentre Trial
It is a prospective and multi-center clinical research in China to compare the efficacy, safety and related impact factors between TACE alone and endovascular brachytherapy combined with stent placement and TACE for HCC with main portal vein tumor thrombus.
Details
| Lead sponsor | Shanghai Zhongshan Hospital |
|---|---|
| Phase | Phase 3 |
| Status | UNKNOWN |
| Enrolment | 253 |
| Start date | 2017-01 |
| Completion | 2020-11 |
Conditions
- Hepatocellular Carcinoma
- Portal Vein Tumor Thrombus
Interventions
- Stent and Iodine-125 seed strand implantation
- Stent
- Iodine-125 seed
- Epirubicin
- Ultra-fluid lipiodol
- Gelatin sponge articles
Primary outcomes
- Overall Survival — From the date of randomization until the date of death from any cause, assessed up to 24 months
Countries
China